Filing Flows › Charles River Laboratories International (CRL) › Net income
Charles River Laboratories International (CRL) net income by quarter
Charles River Laboratories International's net income was $333M in Q3 2026 (third quarter 2026), +512% from Q3 2025. Over the last 4 quarters it ranged from $25.5M (Q1 2025) to $333M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $333M | +512% | +512% |
| Q3 2025 | $54.4M | +3% | — |
| Q2 2025 | $52.7M | +107% | — |
| Q1 2025 | $25.5M | — | — |
Q3 2026 at a glance
Charles River Laboratories International, Q3 2026: revenue $983M (-2% year over year), operating margin 20.6%, net earnings $333M, operating cash flow $254M. The chart follows the revenue to costs, profit and cash.
Questions
What is Charles River Laboratories International's net income?
Charles River Laboratories International's net income was $333M in Q3 2026 (third quarter 2026), +512% from Q3 2025.
How has Charles River Laboratories International's net income changed?
Over the last 4 quarters it ranged from $25.5M (Q1 2025) to $333M (Q3 2026).
Q3 2026 results → · How Charles River Laboratories International makes money →